Fitusiran is a small interference RNA therapeutic designed to prevent bleeds in patients with hemophilia A or B by lowering antithrombin.

This is a major source of cardiovascular morbidity and mortality. We have never been able to treat lipoprotein(a) until now.” ...

As with its predecessor, the new drug candidate, Jun13296, targets a different viral protein than Paxlovid does and works ...

Scientists suggest that targeting a key protein outside of the brain could help ... Precision Medicine Could Be Possible in the Fight Against Antibiotic Resistance Apr. 3, 2025 — Certain ...

The F8 formulation is 8 times more concentrated than Egrifta and 2 times more concentrated than the current F4 formulation, Egrifta SV.

The Food and Drug Administration (FDA) has approved Vykat™ XR (diazoxide choline) for the treatment of hyperphagia in adults and pediatric patients 4 years of age and older with Prader-Willi syndrome ...

Cardamom is a spice that people have used for centuries in cooking and as a medicine. Initially a common ... There is no established dosage for taking cardamom as a supplement.

Vinegar has been used throughout history in both medicine and food preservation ... side effects and dosage information to remember. When you combine apples, sugar and yeast and allow it ...

Sanofi SNY and partner, Alnylam Pharmaceuticals ALNY, announced that the FDA has approved Qfitlia (fitusiran) as the first ...

The antithrombin assay will support dosing Qfitlia, the sixth Alnylam-discovered RNAi medicine to receive FDA approval.